Literature DB >> 1998658

High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts.

J F Oram1, A J Mendez, J P Slotte, T F Johnson.   

Abstract

Cultured cells possess high-affinity binding sites (receptors) for high density lipoprotein (HDL) that appear to mediate removal of excess intracellular cholesterol from cells. To examine the role of intact HDL apoproteins in receptor-mediated cholesterol removal, HDL3 apoproteins were digested with the proteolytic enzymes trypsin and pronase, and the residual particles were used in sterol efflux experiments. Protease treatment abolished the interaction of HDL3 with the 110-kd cell membrane protein postulated to represent the HDL receptor molecule, indicating that this interaction is mediated by HDL apoproteins rather than lipids. Compared with native HDL3 protease-modified HDL3 had a markedly reduced ability to selectively remove sterol from intracellular pools, even though modified particles promoted greater cholesterol efflux from the plasma membrane than did native particles. These results indicate that whereas sterol efflux from plasma membranes is mediated by HDL lipids, removal of excess intracellular sterol from cells is mediated by HDL apoproteins. These findings are consistent with the hypothesis that receptor binding of HDL apoproteins stimulates translocation of excess intracellular sterol to the cell surface where it becomes accessible for removal by HDL or other lipid-rich acceptor particles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998658     DOI: 10.1161/01.atv.11.2.403

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  18 in total

1.  Visualization of the uptake of high-density lipoprotein by rat aortic endothelial cells and smooth muscle cells in vitro.

Authors:  Wei T Chao; Seng S Fan; Vivian C Yang
Journal:  Histochem J       Date:  2002-05

2.  High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells.

Authors:  A Cogny; V Atger; J L Paul; T Soni; N Moatti
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

3.  Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells.

Authors:  G A Francis; A J Mendez; E L Bierman; J W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

4.  Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.

Authors:  A J Mendez; G M Anantharamaiah; J P Segrest; J F Oram
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  Retinoic acid isomers up-regulate ATP binding cassette A1 and G1 and cholesterol efflux in rat astrocytes: implications for their therapeutic and teratogenic effects.

Authors:  Jing Chen; Lucio G Costa; Marina Guizzetti
Journal:  J Pharmacol Exp Ther       Date:  2011-05-31       Impact factor: 4.030

6.  Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis.

Authors:  Jing Chen; Xiaolu Zhang; Handojo Kusumo; Lucio G Costa; Marina Guizzetti
Journal:  Biochim Biophys Acta       Date:  2012-09-23

7.  Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI.

Authors:  C M Allan; N H Fidge; J R Morrison; J Kanellos
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

8.  Omega-3 fatty acids in smooth muscle cell phospholipids increase membrane cholesterol efflux.

Authors:  E Dusserre; T Pulcini; M C Bourdillon; M Ciavatti; F Berthezene
Journal:  Lipids       Date:  1995-01       Impact factor: 1.880

9.  Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.

Authors:  R S McLeod; C Robbins; A Burns; Z Yao; P H Pritchard
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

10.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.